The specific documentation requirements are not published in full at the drug level your prescriber should confirm what records are needed (dietary programs, behavioral interventions, prior medications) before submitting the PA to SelectHealth
This weekly injection for weight loss is generally prescribed to adults living with obesity or those classified as overweight who also have associated health conditions
Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide effect and action in diabetes (LEAD) trials
The GDS-15 was completed by 34 patients (17 per group), with median scores initially at 2.0 in the loading dose group and 3.5 in the no loading dose group, which adjusted to 2.5 and 2.0 respectively after 90 days
Asparagine, especially when followed by glycine in the sequence (Asn-Gly), is a "hot spot" for deamidation
10.1016/0092-8674(88)90263-2 32 GizurarsonS